Potential Targeted Therapy for Type I Diabetes: Monoclonal Antibodies
Innovative study on mice leads to a potential targeted monoclonal antibody therapy to manage Type I diabetes. Study highlights need for human version of antibody.
United States Devi Kasinathan Zheng Guo Dax Fu Johns Hopkins University School Of Medicine Surface Znt
Source: medindia.net